The Organoids Market is undergoing a transformative boom, driven by groundbreaking advances in stem cell research, disease modeling, and personalized medicine. According to recent analysis, the market size is expected to surge from US$ 3.03 billion in 2023 to a remarkable US$ 15.01 billion by 2031, at a CAGR of 22.3% during the forecast period […]
Author: Mrinal Kerhalkar
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal's core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.